Kestrel Therapeutics
Biotechnology
Pagliuca Harvard Life Lab
28 employees
- Employees
- 28
- Contacts
- 3
- Emails
- 3
- Phones
- 2
Kestrel Therapeutics Overview
- Headquarters
- Pagliuca Harvard Life Lab
- Website
- www.kestreltherapeutics.com
- Industry
- Biotechnology
- Employees
- 28
- Funding
- 40.0M
Keywords
About Kestrel Therapeutics
Our goal is to bring new therapy to cancer’s most frequently mutated oncogenic target. Kestrel is discovering and developing new molecules to treat intractable cancers. We are starting with potent inhibitors of pan-oncogenic-RAS. We rely on exceptional science, and our focus, always, is on patients.
Kestrel Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 2
- 50.0% coverage
Kestrel Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Fabien Boulineau | Director, Analytical Development and Cmc | Cambridge, Massachusetts, United States |
Email
|
| Chris O'donnell | Partner, Pfizer Ventures & Vice | United States |
Email
Phone
|
| Ashwin Gollerkeri | Chief Medical Officer at Kestrel | Cambridge, Massachusetts, United States |
Email
Phone
|
| Barbara Sosnowski | Scientist, Leader, Entrepreneur, Drug |
View
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Director
1 profile
Compare Similar Companies to Kestrel Therapeutics
Kymera Therapeutics
Biotechnology Research
Relay Therapeutics
Biotechnology Research
Nimbus Therapeutics
Biotechnology Research
Seaport Therapeutics
Biotechnology Research
ROME Therapeutics
Biotechnology Research
VidaVinci, Inc.
Biotechnology Research
Kojin Therapeutics
Biotechnology Research
Tarveda Therapeutics
Biotechnology Research
HireBioConsulting
Human Resources Services
Anchiano Therapeutics
Biotechnology Research